BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 131523)

  • 1. Cushing syndrome from percutaneous absorption of triamcinolone cream.
    May P; Stein EJ; Ryter RJ; Hirsh FS; Michel B; Levy RP
    Arch Intern Med; 1976 May; 136(5):612-3. PubMed ID: 131523
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary Cushing's syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration.
    Gondwe JS; Davidson JE; Deeley S; Sills J; Cleary AG
    Rheumatology (Oxford); 2005 Nov; 44(11):1457-8. PubMed ID: 16244103
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cushing's syndrome: new diagnostic developments and new treatments].
    te Raa GD; Slee PH
    Ned Tijdschr Geneeskd; 2007 Feb; 151(5):332; author reply 332. PubMed ID: 17326482
    [No Abstract]   [Full Text] [Related]  

  • 4. Four cases of a secondary Cushingoid state following local triamcinolone acetonide (Kenacort) injection.
    Jansen TL; Van Roon EN
    Neth J Med; 2002 Apr; 60(3):151-3. PubMed ID: 12164373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iatrogenic Cushing's syndrome caused by an acute overdose of triamcinolone].
    Girre C; Vincens M; Gompel A; Fournier PE
    Therapie; 1987; 42(3):317-8. PubMed ID: 3660326
    [No Abstract]   [Full Text] [Related]  

  • 6. Cushing's syndrome: complication of triamcinolone injection for urethral strictures in children.
    Augspurger RR; Wettlaufer JN
    J Urol; 1980 Jun; 123(6):932-3. PubMed ID: 7382013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cushing syndrome, adrenal suppression and local corticosteroid use.
    Hameed R; Zacharin MR
    J Paediatr Child Health; 2006 Jun; 42(6):392-4. PubMed ID: 16737485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the effects of local treatment with glucocorticoids only local?
    van Tuyl SA; Slee PH
    Neth J Med; 2002 Apr; 60(3):130-2. PubMed ID: 12164369
    [No Abstract]   [Full Text] [Related]  

  • 9. Iatrogenic Cushing's syndrome after intrapericardial corticosteroid therapy.
    Grubb SR; Cantley LK; Jones DL; Carter WH
    Ann Intern Med; 1981 Dec; 95(6):706-7. PubMed ID: 7305151
    [No Abstract]   [Full Text] [Related]  

  • 10. Unusual complications of triamcinolone injected keloids: tissue necrosis and systemic corticosteroid effects.
    Abdel-Fattah AM
    Br J Plast Surg; 1976 Oct; 29(4):283. PubMed ID: 1000110
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute and persistent iatrogenic Cushing's syndrome after a single dose of triamcinolone acetonide.
    Iglesias P; González J; Díez JJ
    J Endocrinol Invest; 2005 Dec; 28(11):1019-23. PubMed ID: 16483182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorinated corticosteroid toxicity in infants.
    Romano PE; Traisman HS; Green OC
    Am J Ophthalmol; 1977 Aug; 84(2):247-50. PubMed ID: 329678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous absorption of corticosteroids. Adrenocortical suppression with total body inunction.
    Carr RD; Tarnowski WM
    Acta Derm Venereol; 1968; 48(5):417-28. PubMed ID: 4177565
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of long-acting parenteral corticosteroids on adrenal function.
    Mikhail GR; Livingood CS; Mellinger RC; Paige TN; Salyer HL
    Arch Dermatol; 1969 Sep; 100(3):263-8. PubMed ID: 4241801
    [No Abstract]   [Full Text] [Related]  

  • 15. Pituitary-adrenal function following topical triamcinolone acetonide and occlusion.
    Taylor KS; Malkinson FD; Gak C
    Arch Dermatol; 1965 Aug; 92(2):174-7. PubMed ID: 11850923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contact allergy to triamcinolone acetonide].
    Bandmann HJ; Huber-Riffeser G; Woyton A
    Hautarzt; 1966 Apr; 17(4):183-5. PubMed ID: 5986723
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical triamcinolone induced Cushing syndrome: A case report.
    Taylor O; Mejia-Otero JD; Tannin GM; Gordon K
    Pediatr Dermatol; 2020 May; 37(3):582-584. PubMed ID: 32212183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of skin disorders with intramuscular triamcinolone acetonide.
    Rosten M
    N Z Med J; 1970 Oct; 72(461):253-5. PubMed ID: 5275018
    [No Abstract]   [Full Text] [Related]  

  • 19. Cushing syndrome induced by serial occipital nerve blocks containing corticosteroids.
    Lavin PJ; Workman R
    Headache; 2001 Oct; 41(9):902-4. PubMed ID: 11703480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006.
    Stepien KE; Eaton AM; Jaffe GJ; Davis JL; Raja J; Feuer W
    Retina; 2009 Feb; 29(2):207-13. PubMed ID: 19050670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.